Years of caring for children with solid tumors and looking into the eyes of parents starved for hope have led Catherine Bollard to what she calls the most important moment of her career. Children’s ...

New research found only 15% of cancer survivors discussed clinical trials with their healthcare team. Fact checked by Nick Blackmer Cancer deaths have dropped by 33% over the last three decades, in ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Dr. Suneel Kamath addresses patient concerns on the topic of clinical trial participation in the gastrointestinal cancer treatment space. Dr. Suneel Kamath, a gastrointestinal medical oncologist at ...

Clinical trial enrollment is vital for advancing renal cell carcinoma treatment, providing access to innovative therapies and potentially better care. The STELLAR-002 study evaluated zanzalintinib ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the industry.

Semagacestat, tramiprosate, tarenflurbil, latrepirdine: These names may not mean a lot to you, but all four of them were high-profile would-be Alzheimer’s drugs that — in the last two to three years — ...

Why is tokenization important for the future of medicine development? A tremendous amount of data is collected throughout a clinical trial, but prior to tokenization, the life science industry did not ...

Experts say a lack of participation in clinical trials is one reason Black women are 38% more likely to die from breast cancer. A simple question sparked complicated answers: “Would you participate in ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...